Abufaraj Mohammad, Siyam Abdelmuez, Ali Mustafa Rami, Suarez-Ibarrola Rodrigo, Yang Lin, Foerster Beat, Shariat Shahrokh F
Department of Urology, Medical University of Vienna, A-1080 Vienna, Austria.
Division of Urology, Department of Special Surgery, Jordan University Hospital, The University of Jordan, 11942 Amman, Jordan.
Cancers (Basel). 2021 Jan 11;13(2):244. doi: 10.3390/cancers13020244.
To assess the rate and severity of functional outcomes after salvage therapy for radiation recurrent prostate cancer.
This systematic review of the MEDLINE/PubMed database yielded 35 studies, evaluating salvage radical prostatectomy (RP), brachytherapy (BT), high-intensity focal ultrasound (HIFU) and cryotherapy (CT) after failure of primary radiation therapy. Data on pre- and post-salvage rates and severity of functional outcomes (urinary incontinence, erectile dysfunction, and lower urinary tract symptoms) were collected from each study.
The rates of severe urinary incontinence ranged from 28-88%, 4.5-42%, 0-6.5%, 2.4-8% post salvage RP, HIFU, CT and BT, respectively. The rates of erectile dysfunction were relatively high reaching as much as 90%, 94.6%, 100%, 62% following RP, HIFU, CT and BT, respectively. Nonetheless, the high pre-salvage rates of ED preclude accurate estimation of the effect of salvage therapy. There was an increase in the median IPSS following salvage HIFU, BT and CT ranging from 2.5-3.4, 3.5-12, and 2, respectively. Extended follow-up showed a return-to-baseline IPSS in a salvage BT study. The reported data suffer from selection, reporting, publication and period of study biases, making inter-study comparisons inappropriate.
local salvage therapies for radiation recurrent PCa affect continence, lower urinary tract symptoms and sexual functions. The use of local salvage therapies may be warranted in the setting of local disease control, but each individual decision must be made with the informed patient in a shared decision working process.
评估挽救性治疗放射性复发前列腺癌后的功能结局发生率及严重程度。
对MEDLINE/PubMed数据库进行的这项系统评价纳入了35项研究,评估了初次放射治疗失败后的挽救性根治性前列腺切除术(RP)、近距离放射治疗(BT)、高强度聚焦超声(HIFU)和冷冻治疗(CT)。从每项研究中收集挽救性治疗前后功能结局(尿失禁、勃起功能障碍和下尿路症状)的发生率及严重程度数据。
挽救性RP、HIFU、CT和BT后,严重尿失禁的发生率分别为28%-88%、4.5%-42%、0%-6.5%、2.4%-8%。勃起功能障碍的发生率相对较高,RP、HIFU、CT和BT后分别高达90%、94.6%、100%、62%。尽管如此,挽救性治疗前较高的勃起功能障碍发生率妨碍了对挽救性治疗效果的准确评估。挽救性HIFU、BT和CT后,国际前列腺症状评分(IPSS)中位数分别增加2.5-3.4、3.5-12和2。延长随访显示,在一项挽救性BT研究中IPSS恢复至基线水平。所报告的数据存在选择、报告、发表和研究周期偏倚,使得研究间比较不合适。
放射性复发前列腺癌的局部挽救性治疗会影响控尿、下尿路症状和性功能。在局部疾病控制的情况下,可能有必要使用局部挽救性治疗,但每个个体的决策都必须在知情患者参与的共同决策过程中做出。